2 unknown, 2 withdrawn, 1 completed, 1 recruiting. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 2, Withdrawn 2, Completed 1, Recruiting 1 |
| Phase 2 | 2 | Withdrawn 2 |
Follow pirarubicin: new trials by email Literature Review of pirarubicin trials Research Report on pirarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC SHR-1501 for Injection, BCG for Injection, Epirubicin Hydrochloride for Injection - NMIBC | Phase 3 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 236 | 2026-07-13 | 2026-07-20 |
| Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma pegylated liposomal doxorubicin, pirarubicin - Progression-free Survival, Overall Survival | Phase 2 / Phase 3 | Withdrawn | Peking University People's Hospital | 2017-11-06 | 2020-05-19 | |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma Pirarubicin, Oxaliplatin, Lipiodol - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Withdrawn | Guangxi Medical University | 2015-10-01 | 2019-06-04 | |
| Combine TACE and RFA Versus TACE Alone for HCC With PVTT TACE, RFA, pirarubicin,mitomycin and lobaplatin - Hepatocellular Carcinoma | Phase 3 | Unknown | Ming Zhao | 240 | 2014-10-01 | 2016-04-14 |
| Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma liver resection, transarterial chemoembolization, carboplatin - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 198 | 2014-03-01 | 2016-04-28 |
| Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer Pirarubicin, Docetaxel, Cyclophosphamide - Breast Neoplasms | Phase 3 | Completed | 307 Hospital of PLA | 104 | 2009-07-01 | 2015-11-24 |
Carcinoma, Hepatocellular (3) · Breast Neoplasms (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Pathologic Complete Response (1) · Sarcoma (1)
307 Hospital of PLA (1) · Guangxi Medical University (1) · Ming Zhao (1) · Peking University People's Hospital (1) · Sun Yat-sen University (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
China (5)
Lequn Li, PhD (1) · Ming Zhao, doctor (1) · Shikai Wu (1) · Wei Guo, M.D.and Ph.D. (1)